Skip to main content
Log in

Chronisch-entzündliche Darmerkrankungen bei Kindern und Jugendlichen

  • Originalien
  • Published:
Pädiatrie & Pädologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1

Literatur

  1. Timmer A, Behrens R, Buderus S et al (2011) Childhood onset inflammatory bowel disease: predictors of delayed diagnosis from the CEDATA German-language pediatric inflammatory bowel disease registry. J Pediatr 158:467–473.e2

    Google Scholar 

  2. Sawczenko A, Sandhu BK (2003) Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child 88:995–1000

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Van Limbergen J, Russell RK, Drummond HE et al (2008) Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 135:1114–1122

    Article  Google Scholar 

  4. Henderson P, van Limbergen JE, Wilson DC et al (2011) Genetics of childhood-onset inflammatory bowel disease. Inflamm Bowel Dis 17:346–361

    Article  PubMed  Google Scholar 

  5. Shaoul R, Sladek M, Turner D et al (2012) Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn’s disease. Inflamm Bowel Dis 18:1493–1497

    Article  PubMed  Google Scholar 

  6. IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (2005) Inflammatory bowel disease in children and adolescents: recommendations for diagnosis--the Porto criteria. J Pediatr Gastroenterol Nutr 41:1–7

    Google Scholar 

  7. Hyams J, Crandall W, Kugathasan S et al (2007) Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn’s disease in children. Gastroenterology 132:863–873

    Article  CAS  PubMed  Google Scholar 

  8. Hyams J, Damaraju L, Blank M et al (2012) Induction and maintenance therapy with infliximab for children with moderate to severe ulcerative colitis. Clin Gastroenterol Hepatol 10:391–399

    Article  CAS  PubMed  Google Scholar 

  9. Hyams JS, Griffiths A, Markowitz J et al (2012) Safety and efficacy of adalimumab for moderate to severe Crohn’s disease in children. Gastroenterology 143:365–374

    Article  CAS  PubMed  Google Scholar 

  10. Walters TD, Kim M, Denson LA et al (2013) Comparative effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn’s disease. Gastroenterology (im Druck)

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. D. Weghuber gibt an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. Weghuber.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weghuber, D. Chronisch-entzündliche Darmerkrankungen bei Kindern und Jugendlichen. Paediatr. Paedolog. Austria 48, 14–17 (2013). https://doi.org/10.1007/s00608-013-0118-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00608-013-0118-y

Navigation